Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezlotoxumab for CDI Recurrence in Cancer Patients
NCT04415918Phase 4Unknown
- Sponsor
- Cooper University Health Care
- Start
- Jul 2020
- Primary completion
- Jul 2021
01
Overview
A Phase 4 trial of bezlotoxumab in Clostridium difficile infection (CDI), sponsored by Cooper University Health Care. Status: unknown.
02
Drugs
bezlotoxumab
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT04415918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415918.